January 4, 2017 – The Federal Circuit affirmed a reexamination finding of obviousness of certain claims of Ethicon, Inc.’s patent, U.S. Patent No. 7,591,844. Ethicon, Inc. had appealed from a decision following an inter partes reexamination of its patent, which relates to intraluminal medical devices for the local delivery of drugs. The Federal Circuit found that substantial evidence supported the examiner’s finding. The case is 2015-1696 before the Federal Circuit.
By: Katherine E. Adams